myBeST-A Web-Based Survival Prognostic Tool for Women with Breast Cancer in Malaysia: Development Process and Preliminary Validation Study

Int J Environ Res Public Health. 2023 Feb 8;20(4):2985. doi: 10.3390/ijerph20042985.

Abstract

Women with breast cancer are keen to know their predicted survival. We developed a new prognostic model for women with breast cancer in Malaysia. Using the model, this study aimed to design the user interface and develop the contents of a web-based prognostic tool for the care provider to convey survival estimates. We employed an iterative website development process which includes: (1) an initial development stage informed by reviewing existing tools and deliberation among breast surgeons and epidemiologists, (2) content validation and feedback by medical specialists, and (3) face validation and end-user feedback among medical officers. Several iterative prototypes were produced and improved based on the feedback. The experts (n = 8) highly agreed on the website content and predictors for survival with content validity indices ≥ 0.88. Users (n = 20) scored face validity indices of more than 0.90. They expressed favourable responses. The tool, named Malaysian Breast cancer Survival prognostic Tool (myBeST), is accessible online. The tool estimates an individualised five-year survival prediction probability. Accompanying contents were included to explain the tool's aim, target user, and development process. The tool could act as an additional tool to provide evidence-based and personalised breast cancer outcomes.

Keywords: Malaysian women; breast cancer; eHealth; prognosis; web-based tool.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast
  • Breast Neoplasms*
  • Female
  • Humans
  • Internet
  • Malaysia
  • Prognosis

Grants and funding

This research was funded by the Seed Money for Research and Postgraduate Studies Development Incentive Fund (Tabung Insentif Pembangunan Pengajian Siswazah, TIPPS), grant number USM/PPSP/PG/2.0/012 (21) from the School of Medical Sciences, Universiti Sains Malaysia. The article publication fee (APC) was funded by the School of Medical Sciences, Universiti Sains Malaysia.